Foldink is a biotech company focused on spreading 3D bioprinting technology globally. We develop and create bioinks, bioprinters, and other relevant equipment and materials for the benefit of biomedical scientists worldwide.

Founded in 2018 and officially incorporated as Foldink Corp. in 2021, our journey began with four visionary founders: Emmanuel Ghandilyan, Hamlet Khachatryan, Vahan Grigoryan, and Gevork Sarkisyan. Emmanuel, Hamlet, and Vahan, young entrepreneurs with backgrounds in biomedical science and medicine, came together with Gevork, a seasoned business expert and serial entrepreneur. Gevork not only invested his resources but also shared his extensive expertise, enriching the team as a strategic advisor. In 2022, we were fortunate to cross paths with Tigran Oganesov, whose active investment and invaluable strategic insights have further propelled us forward.

Today, Foldink stands as a diverse, international team uniting entrepreneurial minds, accomplished research specialists, skilled engineers, savvy marketers, and a robust scientific and business advisory board. Our collective strength drives us toward a singular goal: pushing the boundaries of bioprinting and beyond. Rooted in a commitment to innovation and reliability, we work tirelessly to harness bioprinting technology for regenerative medicine, therapeutics, and a host of other life-saving applications. At Foldink, we are dedicated to making a tangible difference in the world by pioneering advancements that have the potential to transform countless lives.